The Venture Codex Logo

The Venture Codex

CR-CP Life Science Fund

Room 1903, 19/F Lee Garden One 33 Hysan Avenue Causeway Bay, Causeway Bay, Hong Kong Island, Hong Kong

Overview

Investment firm focused on life sciences and healthcare technology.

Deals · 12mo

0

Links

Website

Stage focus

Series B
Series C

Geographic focus

Belgium
China
Israel
United Kingdom
...

Sector focus

Health Care
Life Science
Medical Device

Investment portfolio

8rounds
NAMEDATESIZE
Novadip Biosciences
Nov 2022Participated
$24 MSeries B
NuProbe
Jun 2022Led
$50 MOther Equity
Novadip Biosciences
Oct 2021Led
$22 MSeries B
EyeYon
Mar 2021Led
$25 MSeries C
ReViral
Aug 2020Led
$44 MSeries C
BELKIN Vision
Jul 2020Participated
$12 MSeries B
CF PharmTech
Jan 2020Participated
$90 MSeries E
Sirnaomics
Apr 2019Led
$22 MSeries C
Novadip Biosciences
Nov 2022Participated
$24 MSeries B
NuProbe
Jun 2022Led
$50 MOther Equity
Novadip Biosciences
Oct 2021Led
$22 MSeries B
EyeYon
Mar 2021Led
$25 MSeries C
ReViral
Aug 2020Led
$44 MSeries C
BELKIN Vision
Jul 2020Participated
$12 MSeries B
CF PharmTech
Jan 2020Participated
$90 MSeries E
Sirnaomics
Apr 2019Led
$22 MSeries C
8
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

CR-CP Life Science Fund: 8 funding rounds are recorded in the selected participation categories.All available history.
CR-CP Life Science Fund: 8 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series B12
Series C+31
Other Equity10

Monthly Deal Activity

CR-CP Life Science Fund: 8 deals are recorded across 91 months.All available history.
CR-CP Life Science Fund: 8 deals are recorded across 91 months. All available history
MonthDeals
Apr '191
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '201
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '201
Aug '201
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '211
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '211
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '221
Jul '220
Aug '220
Sep '220
Oct '220
Nov '221
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

CR-CP Life Science Fund: Health & Life Sciences is the largest displayed sector by deal count (8 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

CR-CP Life Science Fund: Health & Life Sciences is the largest displayed sector by deal count (8 deals). All available history
SectorDeals
Health & Life Sciences8
Manufacturing1
Space & Frontier Tech1

Deal Size Distribution

CR-CP Life Science Fund: 8 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

CR-CP Life Science Fund: 8 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M4
$25M-$50M2
$50M-$100M2
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

CR-CP Life Science Fund: Europe has the largest recorded deal count among the displayed regions (3 deals).All available history.

Top 4 of 4 regions; European countries are grouped as Europe.

CR-CP Life Science Fund: Europe has the largest recorded deal count among the displayed regions (3 deals). All available history
RegionDeals
Europe3
United States2
Israel2
China1
CR-CP Life Science Fund: 20 co-investors are shown, with Fund+ sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

CR-CP Life Science Fund: 20 co-investors are shown, with Fund+ sharing 2 recorded deals. All available history
Co-investorShared deals
Fund+2
InvestSud2
New Science Ventures2
Rimonci Capital2
SRIW2
VIVES Louvain Technology Fund2
Andera Partners1
AZ-CICC Healthcare Investment Fund1
BioLight Life Sciences1
Brace Pharma Capital1
Brighton Park Capital1
C-Mer Eye Care Holdings1
CMB International1
Deguan Capital1
Diamond BioFund1
Finnova Capital1
Global Health Sciences Fund1
Green Sands Equity1
GTJA Investment Group1
Haoreng Capital1

Investment Strategy

CR-CP Life Science Fund: Led accounts for 63% and participating for 38% of round participation.All available history.
CR-CP Life Science Fund: Led accounts for 63% and participating for 38% of round participation. All available history
CategoryDeals (count)Share (%)
Led563%
Participating338%
CR-CP Life Science Fund: Single-lead accounts for 60% and co-led for 40% of lead dynamics.All available history.
CR-CP Life Science Fund: Single-lead accounts for 60% and co-led for 40% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead360%
Co-led240%

Team

Da LIU, MBA and RPH

Managing Director

Jason Zhou

CEO & Managing Director